TSE:EMX EMX Royalty (EMX) Stock Price, News & Analysis → Jim Cramer’s “The Biggest Drug Ever” (From Behind the Markets) (Ad) Free EMX Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get EMX Royalty alerts: Email Address Ad Behind the MarketsJim Cramer’s “The Biggest Drug Ever”This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.Unlock the details of this groundbreaking opportunity here... About EMX Royalty Stock (TSE:EMX)EMX is a precious, base and battery metal royalty company. EMX's investors are provided with discovery, development, and commodity price optionality, while limiting exposure to risks inherent to operating companies.Read More Ad Behind the MarketsJim Cramer’s “The Biggest Drug Ever”This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.Unlock the details of this groundbreaking opportunity here... EMX Stock News HeadlinesJuly 24, 2023 | juniorminingnetwork.comEMX Royalty Options Its Flat and Bamble Nickel Projects in NorwayJune 28, 2023 | finanznachrichten.deEMX Royalty Corp.: EMX Royalty Announces Voting Results from Its 2023 Annual General and Special Meeting of ShareholdersApril 25, 2024 | Behind the Markets (Ad)Jim Cramer’s “The Biggest Drug Ever”This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.June 28, 2023 | finance.yahoo.comEMX Royalty Announces Voting Results from Its 2023 Annual General and Special Meeting of ShareholdersMay 26, 2023 | finanznachrichten.deEMX Royalty Corp.: EMX Royalty Announces First Quarter 2023 ResultsMay 25, 2023 | msn.comMany Peaks names a new cobalt project at Yarrol after promising resultsMay 17, 2023 | markets.businessinsider.comEMX Royalty (EMX) Gets a Buy from H.C. WainwrightMay 15, 2023 | msn.comEMX Royalty Corporation: The One To WatchApril 25, 2024 | Behind the Markets (Ad)Jim Cramer’s “The Biggest Drug Ever”This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.April 12, 2023 | theglobeandmail.comClosing Bell: Emx Royalty Corp down on Tuesday (EMX)April 1, 2023 | benzinga.comEMX Royalty Stock (AMEX:EMX), Short Interest ReportMarch 28, 2023 | finanznachrichten.deEMX Royalty Corp.: EMX Repayment of US$7.85 Million Vendor Take Back NoteMarch 1, 2023 | finanznachrichten.deEMX Royalty Corp.: EMX Executes Agreement to Sell Three Projects in SwedenMarch 1, 2023 | finance.yahoo.comEMX Executes Agreement to Sell Three Projects in SwedenFebruary 15, 2023 | juniorminingnetwork.comWestward Gold Announces Strategic Transaction with EMX Royalty and Mobilizes Diamond Drill RigJanuary 25, 2023 | finanznachrichten.deEMX Royalty Corp.: EMX Royalty Provides an Update on the Diablillos Royalty Property in ArgentinaJanuary 19, 2023 | finance.yahoo.comEMX Royalty Provides an Update on the Diablillos Royalty Property in ArgentinaJanuary 16, 2023 | uk.finance.yahoo.comEMX Royalty: Versatile and reliable like a Swiss Army KnifeSee More Headlines Receive EMX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EMX Royalty and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorOils/Energy Industry Gold Ore Mining Sub-IndustryN/A Current SymbolTSE:EMX CUSIPN/A CIKN/A Webwww.emxroyalty.com Phone16046886390FaxN/AEmployees40Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key CompetitorsOsisko DevelopmentTSE:ODVAugusta ResourceTSE:AZCCrocodile GoldTSE:CRKEOG ResourcesTSE:EOGKiwetinohk EnergyTSE:KEC.TOView All Competitors EMX Stock Analysis - Frequently Asked Questions How do I buy shares of EMX Royalty? Shares of EMX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:EMX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EMX Royalty Corp Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
